SCHEMBL3861069

SCHEMBL3861069

O=C1NCCN1C1(Cc2ccccc2)CCNCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.43
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 2/20 0.43
KMT2A Q03164 2/20 0.43
ALDH1A1 P00352 1/20 0.43
TSHR P16473 1/20 0.43
HIF1A Q16665 1/20 0.43
HSD17B10 Q99714 1/20 0.41
CYP2D6 P10635 2/20 0.40
SIGMAR1 Q99720 2/20 0.39
OPRM1 P35372 1/20 0.36
OPRD1 P41143 1/20 0.36
OPRK1 P41145 1/20 0.36
OPRL1 P41146 1/20 0.36
USP2 O75604 1/20 0.36
DPP4 P27487 1/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
SLC6A3 Q01959 1/20 0.36
ELANE P08246 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16390738 0.80 KMT2A (0.41) MEN1CYP2C9CYP2C19KMT2AALDH1A1
SCHEMBL14279749 0.76 TSHR (0.49) MEN1CYP2C9CYP2C19KMT2AALDH1A1
SCHEMBL3815921 0.74 HSD17B10 (0.51) MEN1CYP2C9CYP2C19KMT2AALDH1A1
SCHEMBL8776703 0.72 CYP2C9 (0.42) MEN1CYP2C9CYP2C19KMT2AALDH1A1
SCHEMBL4124999 0.72 KMT2A (0.44) MEN1CYP2C9CYP2C19KMT2AALDH1A1
SCHEMBL8776796 0.70 LTA4H (0.40) MEN1CYP2C9CYP2C19KMT2AALDH1A1
SCHEMBL4278991 0.69 CYP2D6 (0.44) MEN1CYP2C9CYP2C19KMT2AALDH1A1
SCHEMBL7498000 0.68 TSHR (0.49) MEN1CYP2C9CYP2C19KMT2AALDH1A1
SCHEMBL27820393 0.68 SIGMAR1 (0.46) MEN1CYP2C9CYP2C19KMT2AALDH1A1
SCHEMBL2870036 0.68 SIGMAR1 (0.36) KMT2ATSHRCYP2D6SIGMAR1DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101103020-B Cgrp receptor antagonists MERCK & CO INC 2011-04-27 CN disclosed
EP-1856100-A4 CGRP RECEPTOR ANTAGONISTS MERCK & CO INC (US) 2009-04-15 EP disclosed
CN-101103020-A CGRP receptor antagonists MERCK & CO INC (US) 2008-01-09 CN disclosed
EP-1856100-A2 CGRP RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 2007-11-21 EP disclosed
WO-2006078554-A2 CGRP RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 2006-07-27 WO disclosed